The world's largest conference on HIV and AIDS brought together scientists, policy makers, health-care professionals and people living with HIV.
"We must vigorously defend human rights and put people first," International AIDS Society president and international co-chair Sharon Lewin said at the conference.
Person-centered care was a key focus in many of the sessions held throughout the conference.
Highlights of the week included the results of the PURPOSE 1 study, which looked at the efficacy of a new long-lasting, twice-yearly injection of the drug lenacapavir. According to study results published this week, the twice-a-year injections of lenacapavir were 100% effective in preventing new infections in women.
The drug could be a gamechanger for people living with HIV.
Conference attendees also had a unique opportunity to hear from yet another patient cured of HIV, "Dusseldorf Patient" Marc Franke.
Franke is just one of a handful of people who have successfully been cured of HIV. Attendees also heard a report on a new "Berlin Patient" who has sustained HIV remission for the past five years without the need for antiretroviral medications.